| Chan JK, Loizzi V, Manetta A, et al.
Oral altretamine used as salvage therapy in recurrent ovarian cancer. [Case Reports, Journal Article]
Gynecol Oncol 2004 Jan; 92(1):368-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Medication sheets for patients. Oral chemotherapy. [Journal Article, Patient Education Handout]
Clin J Oncol Nurs 2003 Nov-Dec; 7(6 Suppl):40-72.
Full Citation | Find Related Articles | | Wang C, Gu M, Wang S, et al.
Comparative study on three chemotherapeutic regimens for the treatment of advanced epithelial ovarian cancer. [Journal Article]
J Tongji Med Univ 2000; 20(4):343-4.
Abstract | Full Citation | Find Related Articles | | Keldsen N, Havsteen H, Vergote I, et al.
Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Gynecol Oncol 2003 Feb; 88(2):118-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Harries M, Gore M
Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease. [Journal Article, Review]
Lancet Oncol 2002 Sep; 3(9):537-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hariharan M, Price JC
Solvent, emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine. [Journal Article]
J Microencapsul 2002 Jan-Feb; 19(1):95-109.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Liang X, Lin G, Zhang W, et al.
[Retrospective cohort study on the prognosis of chronic myeloid leukemia] [Journal Article]
Zhonghua Nei Ke Za Zhi 2000 Dec; 39(12):835-7.
Abstract | Full Citation | Find Related Articles | | Harries M, Kaye SB
Recent advances in the treatment of epithelial ovarian cancer. [Journal Article, Review]
Expert Opin Investig Drugs 2001 Sep; 10(9):1715-24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Forbes C, Shirran L, Bagnall AM, et al.
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer. [Journal Article, Review]
Health Technol Assess 2001; 5(28):1-110.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Olver I, Davy M, Lüftner D, et al.
A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer. [Clinical Trial, Clinical Trial, Phase I, Journal Article]
Cancer Chemother Pharmacol 2001 Aug; 48(2):109-14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |    |
|
| |
Advertise on this site.
|
